1. Home
  2. NXL vs PCLA Comparison

NXL vs PCLA Comparison

Compare NXL & PCLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nexalin Technology Inc.

NXL

Nexalin Technology Inc.

HOLD

Current Price

$0.41

Market Cap

8.3M

Sector

Health Care

ML Signal

HOLD

Logo PicoCELA Inc. American Depositary Shares

PCLA

PicoCELA Inc. American Depositary Shares

HOLD

Current Price

$2.30

Market Cap

9.6M

ML Signal

HOLD

Company Overview

Basic Information
Metric
NXL
PCLA
Founded
2010
2008
Country
United States
Japan
Employees
7
55
Industry
Medical Specialities
Building Products
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
8.3M
9.6M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
NXL
PCLA
Price
$0.41
$2.30
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$5.00
N/A
AVG Volume (30 Days)
208.0K
10.6K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$38.28
N/A
Revenue Next Year
$185.71
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.37
$0.12
52 Week High
$2.57
$8.00

Technical Indicators

Market Signals
Indicator
NXL
PCLA
Relative Strength Index (RSI) 36.93 30.86
Support Level $0.37 $0.35
Resistance Level $0.62 $3.74
Average True Range (ATR) 0.03 0.41
MACD 0.00 -0.21
Stochastic Oscillator 8.14 6.77

Price Performance

Historical Comparison
NXL
PCLA

About NXL Nexalin Technology Inc.

Nexalin Technology Inc designs and develops neurostimulation products to uniquely and effectively help combat the ongoing mental health epidemic. The company has developed an easy-to-administer medical device referred to as Generation 1 or Gen-1 that utilizes bioelectronic medical technology to treat anxiety and insomnia, without the need for drugs or psychotherapy. Its original Gen-1 devices are cranial electrotherapy stimulation (CES) devices that emit waveform at 4 milliamps during treatment and are presently classified by the U.S. Food and Drug Administration (FDA) as a Class II device.

About PCLA PicoCELA Inc. American Depositary Shares

PicoCELA Inc specializes in manufacturing, installing, and servicing enterprise wireless mesh solutions. The company generates revenue from two main sources: product equipment sales, and Software as a Service (SaaS) and maintenance services. The company develops the PCWL series of mesh Wi-Fi access points, which utilize its proprietary PicoCELA Backhaul Engine (PBE) technology to enable wireless communication. The company outsources manufacturing and sells these devices directly to customers through distributors. Additionally, the company offers a cloud portal service in a SaaS model, allowing users to monitor connectivity and traffic at their access points. This platform also supports the installation of proprietary edge-computing software into the devices.

Share on Social Networks: